Crossmark

Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK Biobank

Crossref DOI link: https://doi.org/10.1186/s12933-025-02788-4

Published Online: 2025-06-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bertrand, Ambre

Zhou, Xin

Lewis, Andrew

Monfeuga, Thomas

Gupta, Ramneek

Grau, Vicente

Rodriguez, Blanca
Funding

Funding for this research was provided by:

EPSRC Centre for Doctoral Training in Health Data Science (EP/S02428X/1)

Oxford-Bristol Myers Squibb Fellowship (R39207/CN063)

British Heart Foundation Oxford Centre for Research Excellence (RE/18/3/34214)

British Heart Foundation (FS/ICRF/24/26111)

NIHR Oxford Biomedical Research Centre

Novo Nordisk

Wellcome Trust (214290/Z/18/Z)

EPSRC project CompBioMed X (EP/X019446/1)
License Information

Text and Data Mining valid from 2025-06-04

Version of Record valid from 2025-06-04
More Information

Article History

Received: 20 February 2025

Accepted: 13 May 2025

First Online: 4 June 2025

Declarations

:

: TM is employed by Novo Nordisk Research Centre Oxford Ltd. RG consults for Novo Nordisk A/S. TM and RG own minor Novo Nordisk company stock.

Document is current

Any future updates will be listed below